Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. PLoS One, 14(9), e0222178. presented at the 2019. doi:10.1371/journal.pone.0222178. (2019).
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. PLoS One, 13(11), e0206837. presented at the 2018. doi:10.1371/journal.pone.0206837. (2018).
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial. PLoS One, 10(5), e0125914. presented at the 2015. doi:10.1371/journal.pone.0125914. (2015).